Trial Profile
An open-label, randomized, 2-period, cross-over study to determine the relative bioavailability of AEB071 from a coated tablet versus a capsule in healthy subjects
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Sotrastaurin (Primary)
- Indications Liver transplant rejection; Psoriasis; Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Novartis
- 19 Oct 2009 New trial record.